Expressions of TRPV1 in Airway of Asthmatics (NCT02952066) | Clinical Trial Compass
WithdrawnNot Applicable
Expressions of TRPV1 in Airway of Asthmatics
Stopped: Prior to any participant enrollment, the PI opted to not move forward with the study.
United States0Started 2017-09-20
Plain-language summary
The purpose of this study is to measure the density of a temperature-sensitive protein, named TRPV1, in the airway mucosa tissue of both non-asthmatic and moderate to severe persistent asthmatic patients. This study may generate information for developing new therapeutic strategy.
Who can participate
Age range
18 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Competent to understand informed consent
* Diagnosis of moderate to severe persistent allergic asthma.
* Clinical need for diagnostic bronchoscopy for assessment of asthmatic symptoms (e.g., to assess presence of chronic infection with non-tuberculous mycobacteria or other infectious agents as a cause for lack of asthma control) or therapeutic bronchoscopy for management of asthmatic symptoms (e.g., thermoplasty).
* Asthmatic subjects with history of positive skin test to confirm presence of allergy.
* Asthmatic subjects with pre-albuterol forced expiratory volume in the first second (FEV1) of \<70% of the predicted value.
* Non-asthmatic patients will include those patients with solitary pulmonary nodules and healthy individuals with acute lung atelectasis (e.g. airway blocked by mucus plugs or foreign object).
* Scheduled for a diagnostic or therapeutic bronchoscopy procedure.
Exclusion Criteria:
* Inability to perform pulmonary function testing
* Unstable asthma control for asthmatic subjects
* An asthma exacerbation within the past month
* History of intubation for asthma
* History of smoking
* History of prematurity
* History of any lung disease or disorder except asthma
* History of congenital or acquired heart disease
* Pregnant/lactating females
* Any serious concurrent systemic disease including but not limited to diabetes, coronary artery disease, vasculitis, etc.
* History of heart arrhythmias including supraventricular tachycardia
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.